-
SINOVAC receives Nasdaq delisting notice, plans to appeal
-
Sinovac shareholder group pushes for $19 dividend payment
-
SINOVAC appoints UHY LLP as independent auditor to meet NASDAQ requirements
-
SINOVAC board disputes validity of July 8 shareholder meeting
-
SINOVAC board disputes shareholder meeting results amid legal fight
-
SINOVAC begins paying $55 special dividend to shareholders
-
Sinovac's (SVA) Board Urges Shareholders to Vote the WHITE Proxy Card “AGAINST” the Misguided Proposals to Remove SINOVAC’s Current Board
-
Sinovac Biotech (SVA) Board Provides Update on Special Dividend Payment and Commitment to Delivering Value to All Shareholders
-
Vivo Capital Issues Letter to Sinovac (SVA) Shareholders Addressing the Company’s False and Misleading Claims
-
Sinovac Biotech (SVA) Announces New Board Member and Chairman of the Audit Committee
-
Heng Ren Partners Demands Sinovac (SVA) Distribute $8.9 Billion in Cash to its Shareholders and Cause Reinstatement of Trading
-
Sinovac Biotech (SVA) Announces New Board Pursuant to Privy Council Judgment and Order
-
Sinovac Biotech (SVA) Issues Statement Regarding Privy Council Judgment
-
Sinovac Biotech (SVA) Announces Appointment of New CEO

